Browse EV MemProt Atlas
Frequency:
literature support frequency.
EVMP score:

annotation confidence score.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
AN13AQ8IZ07Ankyrin repeat domain-containing protein 13A (Protein KE03)Predicted intracellular proteinsAdhesion and uptake mediationFusion and delivery mediation10.50
ANK2Q01484Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)Disease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsTransportersFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation10.50
ANKL2Q86XL3Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4)Disease related genesEssential proteinsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins1Receptor-signaling mediation10.50
ANO1Q5XXA6Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2)Disease related genesFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters10Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation10.50
APCP25054Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5)Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsClinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation10.50
AQP1P29972Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Channel-like integral membrane protein of 28 kDa) (Urine water channel)Blood group antigen proteinsMetabolic proteinsPredicted membrane proteinsTransporters6Lips/oral mucosa miscellaneous disorderClinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation10.50
AQP10Q96PS8Aquaporin-10 (AQP-10) (Aquaglyceroporin-10) (Small intestine aquaporin)Metabolic proteinsPredicted membrane proteinsTransporters6Fusion and delivery mediation10.50
AQP11Q8NBQ7Aquaporin-11 (AQP-11)6Fusion and delivery mediation10.50
AQP4P55087Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4)Human disease related genesMetabolic proteinsPredicted membrane proteinsTransporters6Fusion and delivery mediationMetabolism mediation10.50
ARH40Q8TER5Rho guanine nucleotide exchange factor 40 (Protein SOLO) (Scambio) (Sabi)Predicted intracellular proteinsImmune mediationReceptor-signaling mediation10.50
ARHGBO15085Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF)Predicted intracellular proteinsReceptor-signaling mediation10.50
ASGR2P07307Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2)Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins1Fusion and delivery mediationMetabolism mediation10.50
ASIC1P78348Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2)2Heart failurePainClinical-translation mediationFusion and delivery mediation10.50
ASTRBQ3KR37Protein Aster-B (GRAM domain-containing protein 1B)Predicted intracellular proteinsPredicted membrane proteinsTransporters1Fusion and delivery mediation10.50
ASTRCQ8IYS0Protein Aster-C (GRAM domain-containing protein 1C)Predicted intracellular proteinsPredicted membrane proteinsTransporters1Fusion and delivery mediation10.50
AT10DQ9P241Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D)EnzymesPredicted membrane proteinsTransporters10Fusion and delivery mediation10.50
AT1A1P05023Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1)Cancer-related genesDisease related genesEnzymesEssential proteinsFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters10Cardiac arrhythmiaChronic obstructive pulmonary diseaseCorneal diseaseHeart failureHyperhidrosisMalariaSolid tumour/cancerSupraventricular tachyarrhythmiaMiddle East Respiratory SyndromeClinical-translation mediationFusion and delivery mediation10.50
AT2A2P16615Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)Disease related genesEnzymesEssential proteinsFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters10AsthmaHeart failureHypertensionClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation10.50
AT2B1P20020Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1)Disease related genesEnzymesFDA approved drug targetsMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters10Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation10.50
AT2B3Q16720Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters10Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation10.50
AT2C2O75185Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 7.2.2.10) (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2) (SPCA2)EnzymesFDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters10Clinical-translation mediationFusion and delivery mediationMetabolism mediation10.50
AT8A2Q9NTI2Phospholipid-transporting ATPase IB (EC 7.6.2.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2)Disease related genesEnzymesHuman disease related genesPotential drug targetsPredicted membrane proteins10Fusion and delivery mediation10.50
AT8B1O43520Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1)Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters10Clinical-translation mediationFusion and delivery mediation10.50
B3GT2O43825Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)1Metabolism mediation10.50
BAIP2Q9UQB8BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53)Plasma proteinsPredicted intracellular proteinsAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation10.50